This means it only up-regulates HGH, but not other hormones like cortisol or adrenocorticotropic hormone (ACTH) [11]
The histologic features of the benign component, be it a blue or cellular blue nevus, are prototypic for the respective entity
The injectable requires subcutaneous injection, starting at a low dose of 0.25 mg weekly for the first four weeks and gradually increasing the dosage monthly
Results depend on dosage consistency, metabolism, lifestyle, and skin type
Dermatological screening for primary lesions involves assessing features such as asymmetry, border irregularity, color variegation, a lesion that looks different from others, changes over time (25)